Checkpoints on Anti-Osteoporosis Medications: Clinical and Biological Considerations - Chair
Michael McClung, MD
Oregon Osteoporosis Center
Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.
If you believe you should have access to this media, please login.
